Current Molecular Medicine

Current Molecular Medicine is an interdisciplinary journal published by Bentham Science Publishers, founded in 2001, focused on molecular medicine, namely the molecular mechanisms of disease pathogenesis, molecular diagnosis and rational treatment, with a 2025 impact factor of 2.8（Current Molecular Medicine）是 Bentham Science Publishers 出版的跨学科期刊，2001 年创刊，聚焦分子医学，即疾病发病的分子机制、分子诊断与靶向治疗，2025 年影响因子为 2.8。

Scope

• It is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, mini-reviews, original research articles, short communications and letters, and drug clinical trial studies是一本跨学科期刊，向读者提供当期而全面的综述、小综述、原创研究论文、短通讯与快报以及药物临床试验研究。
• It focuses on the fundamental molecular mechanisms of disease pathogenesis聚焦疾病发病的基本分子机制。
• It covers the development of molecular diagnosis and novel approaches to rational treatment涵盖分子诊断的发展与理性治疗的新途径。
• Its reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine其综述应为基础研究者与临床研究者共同关注。
• It periodically invites guest editors to devote an issue to a basic research area that shows promise to advance the field定期邀请客座主编就某一有前景的基础研究方向组织专刊。
• It is a peer-reviewed journal that emphasises the rapid publication of peer-reviewed articles是同行评审期刊，强调快速发表经同行评审的文章。

History

• It was founded in 2001, with volume 1, number 1, and has been indexed by MEDLINE since volume 1, number 1 in March 2001该刊 2001 年创刊，第一卷第一期，自 2001 年三月的第一卷第一期起被 MEDLINE 收录。
• It was founded by Bentham Science Publishers as a multidisciplinary journal spanning molecular mechanisms, diagnosis and treatment, and the founding issue carried a Preface signed by Anil Mukherjee由 Bentham Science Publishers 创办，定位为贯通分子机制、诊断与治疗的多学科期刊，创刊号载有 Anil Mukherjee 署名的卷首语。^[1]
• It has no former titles and has been published by Bentham Science Publishers throughout该刊无曾用名，自创刊起一直由 Bentham Science Publishers 出版。
• Its NLM publication place is Hilversum, The Netherlands, while Bentham is now headquartered in Sharjah, United Arab Emirates, with an office in the United StatesNLM 记出版地为荷兰希尔弗瑟姆，而 Bentham 现总部设于阿联酋沙迦，并在美国设办事处。
• NLM records nine issues a year from 2009, while the publisher's 2026 volume 26 masthead lists 14 issuesNLM 记 2009 年起每年九期，而出版方 2026 年第 26 卷刊头标为 14 期。
• Its impact factor is 2.8, its five-year impact factor is 2.7, and its Scopus CiteScore is 4.9其影响因子为 2.8，五年影响因子为 2.7，Scopus CiteScore 为 4.9。

Editors

• The editor-in-chief is Andras Guttman, of the Research Institute of Chemical and Process Engineering at the University of Pannonia in Veszprém, Hungary现任主编 Andras Guttman，匈牙利潘诺尼亚大学化工与过程工程研究所。
• His research field is capillary electrophoresis and separation science, glycomics and glycoproteomics, and biopharmaceutical analysis其研究方向为毛细管电泳与分离科学、糖组学与糖蛋白组学以及生物制药分析。
• The journal also has associate editors, section editors, editorial board members and associate editorial board members, but the full roster is not verifiable because the publisher's editorial board page is blocked该刊另设副编辑、栏目编辑、编委与副编委，但因出版方编委会页被拦截，完整名单不可核验。
• All articles are peer reviewed and authors sign a copyright transfer letter, with submissions made through Bentham's author submission system所有文章均经同行评审，作者须签署版权转让函，投稿经 Bentham 的作者投稿系统提交。
• The journal emphasises publishing peer-reviewed articles rapidly and runs guest-editor special issues, such as the 2007 hot-topic issue on cancer genetics该刊强调快速发表经同行评审的文章，并设客座主编专刊，如 2007 年癌症遗传学热点专题号。^[2]
• Open access articles are also available on ScienceDirect, since the journal is subscription-based with an open access option由于该刊为订阅制并含开放获取选项，其开放获取文章亦在 ScienceDirect 提供。